Decolonization to prevent Staphylococcus aureus transmission and infections in the neonatal intensive care unit

Journal of Perinatology

Volumn 34, Issue 11, 2014, Pages 805-810

  Popoola, V O ^a   Milstone, A M ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PSEUDOMONIC ACID; ANTIINFECTIVE AGENT;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL COLONIZATION; BACTERIAL FLORA; BACTERIAL TRANSMISSION; BACTERIUM CARRIER; BACTERIUM IDENTIFICATION; COST EFFECTIVENESS ANALYSIS; DECOLONIZATION; DRUG SAFETY; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; NEWBORN; NEWBORN INTENSIVE CARE; NONHUMAN; RISK ASSESSMENT; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; ASYMPTOMATIC DISEASE; CROSS INFECTION; HETEROZYGOTE; TRANSMISSION;

ANTI-BACTERIAL AGENTS; ASYMPTOMATIC DISEASES; CARRIER STATE; CROSS INFECTION; HUMANS; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; MUPIROCIN; RISK ASSESSMENT; STAPHYLOCOCCAL INFECTIONS;

EID: 84908609777     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2014.128     Document Type: Article

References (66)

1. Kilham EB. An epidemic of pemphigus neonatorum. Am J Obstet 1889; 22: 1039-1041
2. Hocevar SN, Edwards JR, Horan TC, Morrell GC, Iwamoto M, Lessa FC. Device-associated infections among neonatal intensive care unit patients: incidence and associated pathogens reported to the National Healthcare Safety Network, 2006-2008 Infect Control Hosp Epidemiol 2012; 33(12): 1200-1206
3. Gastmeier P, Loui A, Stamm-Balderjahn S, Hansen S, Zuschneid I, Sohr D et al. Outbreaks in neonatal intensive care units-they are not like others. Am J Infect Control 2007; 35(3): 172-176
4. Hornik CP, Fort P, Clark RH, Watt K, Benjamin DK Jr., Smith PB et al. Early and late onset sepsis in very-low-birth-weight infants from a large group of neonatal intensive care units. Early Hum Dev 2012; 88(Suppl 2): S69-S74
5. Shane AL, Hansen NI, Stoll BJ, Bell EF, Sanchez PJ, Shankaran S et al. Methicillinresistant and susceptible Staphylococcus aureus bacteremia and meningitis in preterm infants. Pediatrics 2012; 129(4): e914-e922
6. Schlapbach LJ, Aebischer M, Adams M, Natalucci G, Bonhoeffer J, Latzin P et al. Impact of sepsis on neurodevelopmental outcome in a swiss national cohort of extremely premature infants. Pediatrics 2011; 128(2): e348-e357
7. Stoll BJ, Hansen NI, Adams-Chapman I, Fanaroff AA, Hintz SR, Vohr B et al. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA 2004; 292(19): 2357-2365
8. Potharst ES, Houtzager BA, van Sonderen L, Tamminga P, Kok JH, Last BF et al. Prediction of cognitive abilities at the age of 5 years using developmental followup assessments at the age of 2 and 3 years in very preterm children. Dev Med Child Neurol 2012; 54(3): 240-246
9. Popoola VO, Budd A, Wittig S.M, Ross T, Aucott S.W, Perl T.M, et al. MRSA transmission and infections in a neonatal intensive care unit despite active surveillance cultures and decolonization-challenges for infection prevention. Infect Control Hosp Epidemiol 2014; 35(4): 412-418
10. Huang YC, Lien RI, Su LH, Chou YH, Lin TY. Successful control of methicillinresistant Staphylococcus aureus in endemic neonatal intensive care units-A 7-year campaign. PLoS One 2011; 6(8): e23001
11. Lessa FC, Edwards JR, Fridkin SK, Tenover FC, Horan TC, Gorwitz RJ. Trends in incidence of late-onset methicillin-resistant Staphylococcus aureus infection in neonatal intensive care units: data from the National Nosocomial Infections Surveillance System, 1995-2004 Pediatr Infect Dis J 2009; 28(7): 577-581
12. Song X, Perencevich E, Campos J, Short BL, Singh N. Clinical and economic impact of methicillin-resistant Staphylococcus aureus colonization or infection on neonates in intensive care units. Infect Control Hosp Epidemiol 2010; 31(2): 177-182
13. Saiman L, Jakob K, Holmes KW, Whittier S, Garzon MC, Rago JV et al. Molecular epidemiology of staphylococcal scalded skin syndrome in premature infants. Pediatr Infect Dis J 1998; 17(4): 329-334
14. Graham PL 3rd, Morel AS, Zhou J, Wu F, Della-Latta P, Rubenstein D et al. Epidemiology of methicillin-susceptible Staphylococcus aureus in the neonatal intensive care unit. Infect Control Hosp Epidemiol 2002; 23(11): 677-682
15. Jimenez-Truque N, Tedeschi S, Saye EJ, McKenna BD, Langdon W, Wright JP et al. Relationship between maternal and neonatal Staphylococcus aureus colonization. Pediatrics 2012; 129(5): e1252-e1259
16. Mitsuda T, Arai K, Fujita S, Yokota S. Demonstration of mother-to-infant transmission of Staphylococcus aureus by pulsed-field gel electrophoresis. Eur J Pediatr 1996; 155(3): 194-199
17. Popoola VO, Carroll KC, Ross T, Reich NG, Perl TM, Milstone AM. Impact of colonization pressure and strain type on MRSA transmission in children. Clin Infect Dis 2013; 57(10): 1458-1460
18. Williams VR, Callery S, Vearncombe M, Simor AE. The role of colonization pressure in nosocomial transmission of methicillin-resistant Staphylococcus aureus. Am J Infect Control 2009; 37(2): 106-110
19. Merrer J, Santoli F, Appere de Vecchi C, Tran B, De Jonghe B, Outin H. Colonization pressure and risk of acquisition of methicillin-resistant Staphylococcus aureus in a medical intensive care unit. Infect Control Hosp Epidemiol 2000; 21(11): 718-723
20. Milstone AM, Goldner BW, Ross T, Shepard JW, Carroll KC, Perl TM. Methicillinresistant Staphylococcus aureus colonization and risk of subsequent infection in critically ill children: importance of preventing nosocomial methicillin-resistant Staphylococcus aureus transmission. Clin Infect Dis 2011; 53(9): 853-859
21. Sakaki H, Nishioka M, Kanda K, Takahashi Y. An investigation of the risk factors for infection with methicillin-resistant Staphylococcus aureus among patients in a neonatal intensive care unit. Am J Infect Control 2009; 37(7): 580-586
22. Gerber SI, Jones RC, Scott MV, Price JS, Dworkin MS, Filippell MB et al. Management of outbreaks of methicillin-resistant Staphylococcus aureus infection in the neonatal intensive care unit: a consensus statement. Infect Control Hosp Epidemiol 2006; 27(2): 139-145
23. Carey AJ, Della-Latta P, Huard R, Wu F, Graham PL 3rd, Carp D et al. Changes in the molecular epidemiological characteristics of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2010; 31(6): 613-619
24. Myers PJ, Marcinak J, David MZ, Zychowski DL, Boyle-Vavra S, Weber S et al. Universal admission screening for methicillin-resistant Staphylococcus aureus in a Level IIID Neonatal Intensive Care Unit: the first 9 months. Infect Control Hosp Epidemiol 2011; 32(4): 398-400
25. Huang YC, Chou YH, Su LH, Lien RI, Lin TY. Methicillin-resistant Staphylococcus aureus colonization and its association with infection among infants hospitalized in neonatal intensive care units. Pediatrics 2006; 118(2): 469-474
26. Song X, Cheung S, Klontz K, Short B, Campos J, Singh N. A stepwise approach to control an outbreak and ongoing transmission of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. Am J Infect Control 2010; 38(8): 607-611
27. Maraqa NF, Aigbivbalu L, Masnita-Iusan C, Wludyka P, Shareef Z, Bailey C et al. Prevalence of and risk factors for methicillin-resistant Staphylococcus aureus colonization and infection among infants at a level III neonatal intensive care unit. Am J Infect Control 2011; 39(1): 35-41
28. Siegel JD, Rhinehart E, Jackson M, Chiarello L, Committee HICPA. Management of Multidrug-Resistant Organisms in Healthcare Settings, 2006. Am J Infect Control 2007; 35(10 Suppl 2): S165-S193
29. Milstone AM, Song X, Coffin S, Elward A. Identification and eradication of methicillin-resistant Staphylococcus aureus colonization in the neonatal intensive care unit: results of a national survey. Infect Control Hosp Epidemiol 2010; 31(7): 766-768
30. Heinrich N, Mueller A, Bartmann P, Simon A, Bierbaum G, Engelhart S. Successful management of an MRSA outbreak in a neonatal intensive care unit. Eur J Clin Microbiol Infect Dis 2011; 30(7): 909-913
31. Hitomi S, Kubota M, Mori N, Baba S, Yano H, Okuzumi K et al. Control of a methicillin-resistant Staphylococcus aureus outbreak in a neonatal intensive care unit by unselective use of nasal mupirocin ointment. J Hosp Infect 2000; 46(2): 123-129
32. Jernigan JA, Titus MG, Groschel DH, Getchell-White S, Farr BM. Effectiveness of contact isolation during a hospital outbreak of methicillin-resistant Staphylococcus aureus. Am J Epidemiol 1996; 143(5): 496-504
33. Milstone AM, Budd A, Shepard JW, Ross T, Aucott S, Carroll KC et al. Role of decolonization in a comprehensive strategy to reduce methicillin-resistant Staphylococcus aureus infections in the neonatal intensive care unit: an observational cohort study. Infect Control Hosp Epidemiol 2010; 31(5): 558-560
34. Delaney HM, Wang E, Melish M. Comprehensive strategy including prophylactic mupirocin to reduce Staphylococcus aureus colonization and infection in high-risk neonates. J Perinatol 2012; 33(4): 313-318
35. You JH, Chan CY, Wong MY, Ip M. Active surveillance and decolonization of methicillin-resistant Staphylococcus aureus on admission to neonatal intensive care units in Hong Kong: a cost-effectiveness analysis. Infect Control Hosp Epidemiol 2012; 33(10): 1024-1030
36. Saiman L, Cronquist A, Wu F, Zhou J, Rubenstein D, Eisner W et al. An outbreak of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2003; 24(5): 317-321
37. Khoury J, Jones M, Grim A, Dunne WM Jr., Fraser V. Eradication of methicillinresistant Staphylococcus aureus from a neonatal intensive care unit by active surveillance and aggressive infection control measures. Infect Control Hosp Epidemiol 2005; 26(7): 616-621
38. Fraser TG, Fatica C, Scarpelli M, Arroliga AC, Guzman J, Shrestha NK et al. Decrease in Staphylococcus aureus colonization and hospital-acquired infection in a medical intensive care unit after institution of an active surveillance and decolonization program. Infect Control Hosp Epidemiol 2010; 31(8): 779-783
39. Bode LG, Kluytmans JA, Wertheim HF, Bogaers D, Vandenbroucke-Grauls CM, Roosendaal R et al. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl J Med 2010; 362(1): 9-17
40. Robicsek A, Beaumont JL, Paule SM, Hacek DM, Thomson RB Jr, Kaul KL et al. Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals. Ann Intern Med 2008; 148(6): 409-418
41. Ridenour G, Lampen R, Federspiel J, Kritchevsky S, Wong E, Climo M. Selective use of intranasal mupirocin and chlorhexidine bathing and the incidence of methicillin-resistant Staphylococcus aureus colonization and infection among intensive care unit patients. Infect Control Hosp Epidemiol 2007; 28(10): 1155-1161
42. Rosenthal A, White D, Churilla S, Brodie S, Katz KC. Optimal surveillance culture sites for detection of methicillin-resistant Staphylococcus aureus in newborns. J Clin Microbiol 2006; 44(11): 4234-4236
43. Nubel U, Nachtnebel M, Falkenhorst G, Benzler J, Hecht J, Kube M et al. MRSA transmission on a neonatal intensive care unit: epidemiological and genomebased phylogenetic analyses. PLoS One 2013; 8(1): e54898
44. Worby CJ, Jeyaratnam D, Robotham JV, Kypraios T, O'Neill PD, De Angelis D et al. Estimating the effectiveness of isolation and decolonization measures in reducing transmission of methicillin-resistant Staphylococcus aureus in hospital general wards. Am J Epidemiol 2013; 177(11): 1306-1313
45. Chapman AK, Aucott SW, Milstone AM. Safety of chlorhexidine gluconate used for skin antisepsis in the preterm infant. J Perinatol 2012; 32(1): 4-9
46. Tamma PD, Aucott SW, Milstone AM. Chlorhexidine use in the neonatal intensive care unit: results from a national survey. Infect Control Hosp Epidemiol 2010; 31(8): 846-849
47. Chapman AK, Aucott SW, Gilmore MM, Advani S, Clarke W, Milstone AM. Absorption and tolerability of aqueous chlorhexidine gluconate used for skin antisepsis prior to catheter insertion in preterm neonates. J Perinatol 2013; 33(10): 768-771
48. Lepelletier D, Corvec S, Caillon J, Reynaud A, Roze JC, Gras-Leguen C. Eradication of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit: which measures for which success? Am J Infect Control 2009; 37(3): 195-200
49. Huang SS, Septimus E, Kleinman K, Moody J, Hickok J, Avery TR et al. Targeted versus universal decolonization to prevent ICU infection. N Engl J Med 2013; 368 (24): 2255-2265
50. van Rijen M, Bonten M, Wenzel R, Kluytmans J. Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers. Cochrane Database Syst Rev 2008; (4): CD006216
51. Iida N, Dzutsev A, Stewart CA, Smith L, Bouladoux N, Weingarten RA et al. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science 2013; 342(6161): 967-970
52. Grainger JR, Wohlfert EA, Fuss IJ, Bouladoux N, Askenase MH, Legrand F et al. Inflammatory monocytes regulate pathologic responses to commensals during acute gastrointestinal infection. Nat Med 2013; 19(6): 713-721
53. Belkaid Y, Naik S. Compartmentalized and systemic control of tissue immunity by commensals. Nat Immunol 2013; 14(7): 646-653
54. Belkaid Y, Bouladoux N, Hand TW. Effector and memory T cell responses to commensal bacteria. Trends Immunol 2013; 34(6): 299-306
55. Aurora R, Chatterjee D, Hentzleman J, Prasad G, Sindwani R, Sanford T. Contrasting the microbiomes from healthy volunteers and patients with chronic rhinosinusitis. JAMA 2013; 139(12): 1328-1338
56. GlaxoSmithKline. BACTROBAN NASAL (mupirocin calcium ointment, 2%). Human Prescription Drug Label [Internet] 2005 10/24/2012. Available at: http://dailymed.nlm. nih.gov/dailymed/getFile.cfm?setid=6dd5868f-0bc2-48c8-238b-e857f5bd812f&type= pdf&name=6dd5868f-0bc2-48c8-238b-e857f5bd812f (accessed 30 January 2014)
57. Case DE. Chlorhexidine: attempts to detect percutanous absorption in man. Proc Int Congr Chemother 1976; 3: 367-374
58. Reynolds PR, Banerjee S, Meek JH. Alcohol burns in extremely low birthweight infants: still occurring. Arch Dis Child Fetal Neonatal Ed 2005; 90(1): F10
59. Watkins AM, Keogh EJ. Alcohol burns in the neonate. J Paediatr Child Health 1992; 28(4): 306-308
60. Bringue Espuny X, Soria X, Sole E, Garcia J, Marco JJ, Ortega J et al. Chlorhexidinemethanol burns in two extreme preterm newborns. Pediatr Dermatol 2010; 27(6): 676-678
61. Mullany LC, Darmstadt GL, Tielsch JM. Safety and impact of chlorhexidine antisepsis interventions for improving neonatal health in developing countries. Pediatr Infect Dis J 2006; 25(8): 665-675
62. Miller MA, Dascal A, Portnoy J, Mendelson J. Development of mupirocin resistance among methicillin-resistant Staphylococcus aureus after widespread use of nasal mupirocin ointment. Infect Control Hosp Epidemiol 1996; 17(12): 811-813
63. Jones JC, Rogers TJ, Brookmeyer P, Dunne WM Jr., Storch GA, Coopersmith CM et al. Mupirocin resistance in patients colonized with methicillin-resistant Staphylococcus aureus in a surgical intensive care unit. Clin Infect Dis 2007; 45(5): 541-547
64. Choudhury S, Krishnan PU, Ang B. Prevalence of high-level mupirocin resistance among meticillin-resistant Staphylococcus aureus isolates in a tertiary care hospital in Singapore. J Hosp Infect 2012; 82(1): 56-57
65. Patel JB, Gorwitz RJ, Jernigan JA. Mupirocin resistance. Clin Infect Dis 2009; 49(6): 935-941
66. Otter JA, Patel A, Cliff PR, Halligan EP, Tosas O, Edgeworth JD. Selection for qacA carriage in CC22, but not CC30, methicillin-resistant Staphylococcus aureus bloodstream infection isolates during a successful institutional infection control programme. J Antimicrob Chemother 2013; 68(5): 992-999